Improper solvent selection, incorrect volumes, insufficient buffering, or low-grade reagents may result in clumping, cloudiness, gelling, aggregation, or incomplete dissolution
BPC-157 has become one of the most talked-about peptides in wellness and recovery circles, and for good reason
Read review Dihexa for ME/CFS (Myalgic Encephalomyelitis) DecodeME GWAS preprint Aug 2025 (8 loci, female-only signal), UK ME/CFS Delivery Plan My Full Reality July 2025, NIH Walitt 2024 deep-phenotyping, UBC Nacul LDN trial, NICE NG206, and the ~250,000 UK ME/CFS population
Status: Research phase No completed human RCTs Not FDA-approved SC injection or oral (research only) Caveat: BPC-157 is under review at the FDA's July 2026 peptide advisory panel and is currently restricted for compounding
Q3: What is a typical DSIP dose used in research